Table 1.
Characteristics | |
No. of evaluable patients | 67 |
Age, year | |
Median | 57 |
Range | 32–87 |
Recurrence | |
N | 12 (17.91) |
Prog | 19 (28.36) |
Y | 36 (53.73) |
Progressive disease | |
Missing | 34 (50.75) |
N | 3 (4.48) |
Y | 30 (44.78) |
Status | |
Alive with evidence of disease | 23 (34.33) |
Alive with no evidence of disease | 17 (25.37) |
DOD | 27 (40.3) |
Fibrosis | |
1 | 24 (35.82) |
2 | 16 (23.88) |
3 | 27 (40.3) |
RT | |
1 | 29 (43.28) |
2 | 22 (32.84) |
3 | 16 (23.88) |
Necrosis | |
0 | 40 (59.7) |
1 | 19 (28.36) |
2 | 8 (11.94) |
Inflammation | |
1 | 36 (53.73) |
2 | 31 (46.27) |
Data in parentheses are percentages.